BTIG Reiterates Neutral Rating on Embecta (EMBC) May 11, 2026 05:32AM
Embecta (EMBC) PT Lowered to $5 at Mizuho May 6, 2026 05:14AM
BTIG Downgrades Embecta (EMBC) to Neutral, 'surprisingly weak F2Q print' May 5, 2026 04:12PM
Embecta Corp. (EMBC) Misses Q2 EPS by 15c; offers guidance May 5, 2026 07:53AM
BTIG stays Buy on Embecta (EMBC) following Owen Mumford acquisition announcement Mar 19, 2026 08:20AM


Feb 11, 2026 04:12PM Embecta names Devdatt Kurdikar as board chairman
Feb 5, 2026 06:34AM Embecta Corp. (EMBC) Tops Q1 EPS by 4c
Nov 25, 2025 11:14AM BTIG on Embecta (EMBC): 'Fast Pace of Debt Paydown and Strong FCF Generation to Continue'
Nov 25, 2025 06:31AM Embecta Corp. (EMBC) Tops Q4 EPS by 4c, Misses on Revenue; Offers FY26 Guidance
Nov 14, 2025 08:30AM embecta Announces Major New Commitment to Direct Relief on World Diabetes Day
Sep 19, 2025 06:01AM BTIG Reiterates Buy Rating on Embecta (EMBC)
Sep 8, 2025 05:29AM Embecta (EMBC) October 17.5 calls active
Aug 11, 2025 06:50AM Embecta (EMBC) PT Raised to $14 at Mizuho
Aug 8, 2025 06:31AM Embecta Corp. (EMBC) Tops Q3 EPS by 35c, Beats on Revenue; Offers FY25 Guidance
May 29, 2025 05:33AM Embecta (EMBC) PT Lowered to $18 at BofA Securities
May 9, 2025 06:34AM Embecta Corp. (EMBC) Tops Q2 EPS by 17c ; Offers Guidance
Apr 9, 2025 04:17PM Mizuho Starts Embecta (EMBC) at Neutral
Nov 27, 2024 06:05AM BTIG Upgrades Embecta (EMBC) to Buy
Sep 3, 2024 06:32AM Embecta (EMBC) Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes